Literature DB >> 17447069

Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.

Rim Sghiri1, Elyes Bouagina, Hela Zaglaoui, Hajer Mestiri, Latifa Harzallah, Imed Harrabi, Mehdi Ghannouchi, Faycel Mokhtar, Ibtissem Ghedira.   

Abstract

To evaluate the rheumatoid arthritis (RA) diagnostic performances of anti-cyclic citrullinated peptide antibodies (anti-CCP). Anti-CCP was detected by an enzyme linked immunosorbent assay in 164 patients with RA and 343 controls. In addition, anti-CCP predictive value for radiological damage were investigated in 37 recent-onset RA patients followed up prospectively for 2 years. Radiological damages were assessed by Sharp method modified by van der Heijde. The sensitivity of anti-CCP was 78.7% and the specificity was 95.6%. The positive predictive value and the negative predictive value were 90.2% and 90.3%, respectively. Anti-CCP were detected in sera of 79.3% of patients with recent onset RA and 78.3% of patients with long disease duration. In univariate and multivariate analyses, anti-CCP were not predictive for radiological damage. Our study confirms the high diagnostic performances of anti-CCP in RA. They are very useful to aid the diagnostic of RA in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447069     DOI: 10.1007/s00296-007-0351-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  38 in total

1.  The relation between class-specific serum rheumatoid factors and age in the general population.

Authors:  D van Schaardenburg; A M Lagaay; H G Otten; F C Breedveld
Journal:  Br J Rheumatol       Date:  1993-07

2.  Diagnostic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis.

Authors:  N Bizzaro; G Mazzanti; E Tonutti; D Villalta; R Tozzoli
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

3.  Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis.

Authors:  S Bas; S Genevay; O Meyer; C Gabay
Journal:  Rheumatology (Oxford)       Date:  2003-05       Impact factor: 7.580

Review 4.  Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review.

Authors:  J Avouac; L Gossec; M Dougados
Journal:  Ann Rheum Dis       Date:  2006-04-10       Impact factor: 19.103

5.  The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

Authors:  E J Kroot; B A de Jong; M A van Leeuwen; H Swinkels; F H van den Hoogen; M van't Hof; L B van de Putte; M H van Rijswijk; W J van Venrooij; P L van Riel
Journal:  Arthritis Rheum       Date:  2000-08

6.  Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.

Authors:  G A Schellekens; B A de Jong; F H van den Hoogen; L B van de Putte; W J van Venrooij
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

7.  Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis.

Authors:  B Vander Cruyssen; I E A Hoffman; H Zmierczak; M Van den Berghe; E Kruithof; L De Rycke; H Mielants; E M Veys; D Baeten; F De Keyser
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

8.  The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis.

Authors:  Louise M A Jansen; Dirkjan van Schaardenburg; Irene van der Horst-Bruinsma; Rob J van der Stadt; Margret H M T de Koning; Ben A C Dijkmans
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

9.  Anti-cyclic citrullinated peptide antibodies in hepatitis C virus associated rheumatological manifestations and Sjogren's syndrome.

Authors:  D Sène; P Ghillani-Dalbin; N Limal; V Thibault; T van Boekel; J-C Piette; P Cacoub
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

10.  Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseases.

Authors:  S Dubucquoi; E Solau-Gervais; D Lefranc; L Marguerie; J Sibilia; J Goetz; V Dutoit; A-L Fauchais; E Hachulla; R-M Flipo; L Prin
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

View more
  10 in total

Review 1.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

2.  Serum anti-cyclic citrullinated peptide antibodies may predict disease activity in rheumatoid arthritis.

Authors:  Kamal Esalatmanesh; Raika Jamali; Arsia Jamali; Bardia Jamali; Mohammadreza Nikbakht
Journal:  Rheumatol Int       Date:  2011-12-21       Impact factor: 2.631

3.  Frequency of serological markers of rheumatoid arthritis in patients with IgA anti-β2 glycoprotein I antibodies.

Authors:  Sarra Melayah; Mariem Ghozzi; Amani Mankaï; Fatma Mechi; Ibtissem Ghedira
Journal:  J Clin Lab Anal       Date:  2022-06-06       Impact factor: 3.124

4.  Serum levels of anti-cyclic citrullinated peptide antibodies are associated with a beneficial response to traditional herbal medicine (Kampo) in rheumatoid arthritis.

Authors:  Toshiaki Kogure; Hiroko Sato; Daijiro Kishi; Tomoyuki Ito; Takeshi Tatsumi
Journal:  Rheumatol Int       Date:  2009-02-22       Impact factor: 2.631

5.  Value of anti-mutated citrullinated vimentin antibodies in diagnosing rheumatoid arthritis.

Authors:  Rim Sghiri; Elyes Bouajina; Dhaker Bargaoui; Latifa Harzallah; Hosni Ben Fredj; Samar Sammoud; Ibtissem Ghedira
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

6.  Frequency of serological markers of rheumatoid arthritis in adult patients with active celiac disease.

Authors:  Mariam Ghozzi; Sarra Melayah; Najeh Adaily; Ibtissem Ghedira
Journal:  J Clin Lab Anal       Date:  2022-01-20       Impact factor: 2.352

7.  A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis.

Authors:  Peter Taylor; Juliane Gartemann; Jeanie Hsieh; James Creeden
Journal:  Autoimmune Dis       Date:  2011-09-11

8.  Anti-cyclic citrullinated peptide antibodies and joint involvement in Behçet's disease.

Authors:  Sung Bin Cho; Ju Hee Lee; Keun Jae Ahn; Byung Gi Bae; Taegyun Kim; Yong-Beom Park; Soo-Kon Lee; Kwang Hoon Lee; Dongsik Bang
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

9.  Validation of a prediction rule for the diagnosis of rheumatoid arthritis in patients with recent onset undifferentiated arthritis.

Authors:  Zaida Bedran; Cristian Quiroz; Javier Rosa; Luis J Catoggio; Enrique R Soriano
Journal:  Int J Rheumatol       Date:  2013-02-28

10.  IgA is the predominant isotype of anti-β2 glycoprotein I antibodies in rheumatoid arthritis.

Authors:  Sarra Melayah; Maha Changuel; Amani Mankaï; Ibtissem Ghedira
Journal:  J Clin Lab Anal       Date:  2020-01-22       Impact factor: 2.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.